Inovio Pharmaceuticals, Inc.
INO
$1.31
-$0.01-0.67%
NASDAQ
| 06/30/2026 | 03/31/2026 | 12/31/2025 | 09/30/2025 | 06/30/2025 | |
|---|---|---|---|---|---|
| Net Income | 23.17% | 11.97% | 20.80% | 4.24% | 27.85% |
| Total Depreciation and Amortization | -0.39% | -3.94% | -4.50% | 19.03% | 8.25% |
| Total Amortization of Deferred Charges | -- | -- | -- | -- | -- |
| Total Other Non-Cash Items | -456.20% | 303.57% | -6.12% | 502.20% | -111.88% |
| Change in Net Operating Assets | 24.73% | 9.54% | -245.92% | -51.81% | 3.47% |
| Cash from Operations | 14.99% | 18.44% | 14.84% | 19.66% | 15.63% |
| Capital Expenditure | -116.39% | 55.77% | 41.44% | 67.55% | 81.49% |
| Sale of Property, Plant, and Equipment | -- | -- | -- | -60.01% | -60.01% |
| Cash Acquisitions | -- | -- | -- | -- | -- |
| Divestitures | -- | -- | -- | -- | -- |
| Other Investing Activities | -67.05% | -71.31% | -86.29% | -45.56% | -23.03% |
| Cash from Investing | -67.39% | -71.47% | -86.51% | -45.46% | -22.70% |
| Total Debt Issued | -- | -- | -- | -- | -- |
| Total Debt Repaid | -- | -- | -- | 100.00% | 100.00% |
| Issuance of Common Stock | 165.33% | 13.06% | 0.20% | -11.01% | -40.36% |
| Repurchase of Common Stock | -62.91% | 47.99% | 73.66% | 73.66% | 72.78% |
| Issuance of Preferred Stock | -- | -- | -- | -- | -- |
| Repurchase of Preferred Stock | -- | -- | -- | -- | -- |
| Total Dividends Paid | -- | -- | -- | -- | -- |
| Other Financing Activities | 92.67% | -47.26% | -47.26% | 104.69% | -0.51% |
| Cash from Financing | 127.82% | -17.05% | 3.06% | 127.82% | 27.24% |
| Foreign Exchange rate Adjustments | -- | -- | -- | -100.00% | -100.00% |
| Miscellaneous Cash Flow Adjustments | -- | -- | -- | -- | -- |
| Net Change in Cash | 171.45% | -167.17% | -141.82% | 416.12% | 45.19% |